|  Help  |  About  |  Contact Us

Publication : Involvement of Sema4A in the progression of experimental autoimmune myocarditis.

First Author  Makino N Year  2008
Journal  FEBS Lett Volume  582
Issue  28 Pages  3935-40
PubMed ID  18977352 Mgi Jnum  J:143233
Mgi Id  MGI:3823194 Doi  10.1016/j.febslet.2008.10.040
Citation  Makino N, et al. (2008) Involvement of Sema4A in the progression of experimental autoimmune myocarditis. FEBS Lett 582(28):3935-3940
abstractText  Dilated cardiomyopathy often results from autoimmunity triggered by microbial infections during myocarditis. However, it remains unclear how immunological disorders are implicated in pathogenesis of autoimmune myocarditis. Here, we demonstrated that Sema4A, a class IV semaphorin, plays key roles in experimental autoimmune myocarditis (EAM). Dendritic cells pulsed with myosin heavy chain-alpha peptides induced severe myocarditis in wild-type mice, but not in Sema4A-deficient mice. In adoptive transfer experiments, CD4(+) T-cells from wild-type mice induced severe myocarditis, while CD4(+) T-cells from Sema4A-deficient mice exhibited considerably attenuated myocarditis. Our results indicated that Sema4A is critically involved in EAM by regulating differentiation of T-cells.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression